# Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT)

> **NCT07749911** · — · RECRUITING · sponsor: **Clinton Health Access Initiative Inc.** · enrollment: 20000 (estimated)

## Conditions studied

- Malaria
- PLASMODIUM FALCIPARUM MALARIA

## Interventions

- **BIOLOGICAL:** R21/Matris-M Malaria vaccine

## Key facts

- **NCT ID:** NCT07749911
- **Lead sponsor:** Clinton Health Access Initiative Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-14
- **Primary completion:** 2027-06
- **Final completion:** 2027-08
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2026-08-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749911, "Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07749911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*